IPP Bureau
U.S. FDA approves Novartis Leqvio to lower cholestrol
By IPP Bureau - December 23, 2021
With two maintenance doses a year, Leqvio is the first and only FDA-approved small interfering RNA (siRNA) therapy for LDL-C (bad cholesterol) reduction1
Windlas Biotech appoints Shailendra Rastogi as CBO
By IPP Bureau - December 22, 2021
He has over 22 years of experience in pharmaceutical sales & business development
Piramal Pharma takes a minority stake in Yapan Bio
By IPP Bureau - December 22, 2021
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
By IPP Bureau - December 22, 2021
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Merck acquires Chord Therapeutics to expand its neuroinflammatory pipeline
By IPP Bureau - December 22, 2021
Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
Novartis to acquire Gyroscope Therapeutics for up to US $ 1.5 bn
By IPP Bureau - December 22, 2021
Acquisition will add GT005 to the Novartis portfolio, an investigational, one-time gene therapy currently in Phase 2 for the treatment of people living with Geographic atrophy
Thermo Fisher Scientific updates its Covid-19 panel to detect Omicron
By IPP Bureau - December 22, 2021
The TaqMan SARS CoV-2 Mutation Panel is compatible with real-time PCR instruments already commonly used in laboratories around the world
Sputnik Light booster after Sputnik V effective against Omicron: Study
By IPP Bureau - December 22, 2021
Sputnik Light as a booster significantly increases virus neutralizing activity against Omicron based on sera 2-3 months after revaccination
AquaCentric Therapy opens up for treatment of autism care
By IPP Bureau - December 22, 2021
Autism spectrum disorder affects 78 million people and families worldwide
A 39-year-old patient with Covid-19 was saved with ECMO support
By IPP Bureau - December 22, 2021
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
Stelis commissions vaccine facility in Bengaluru
By IPP Bureau - December 21, 2021
The company has started manufacturing the Sputnik Light vaccine
Sandoz submits Biologics License Application for proposed biosimilar trastuzumab to US FDA
By IPP Bureau - December 21, 2021
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
CDSCO increases shelf life of Covaxin
By IPP Bureau - December 21, 2021
The approval of shelf life extension is based on the availability of additional stability data, which was submitted to the CDSCO
Novartis collaborates with BeiGene to strengthen immunotherapy pipeline
By IPP Bureau - December 21, 2021
Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis
U.S. FDA approves first and only injectable option for HIV prevention
By IPP Bureau - December 21, 2021
Given as few as six times per year and demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition
